Skip to main content
. 2021 Apr;19(4):538–552. doi: 10.2174/1570159X18666200529151741

Fig. (8).

Fig. (8)

Results of the meta-analysis of the evaluation of weight gain on treatment with risperidone: (A) short-term (until up 8 weeks); (B) long-term (after 8 weeks); (C) versus placebo in short-term (until up 8 weeks); (D) versus placebo in long-term (after 8 weeks). Confidence Interval (CI), Heterogeneity (I2) and heterogeneity’s p-value (p).